Abdullah, Nympha D.

HRN: 25-10-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/03/2024
05/10/2024
IV DRIP
4.5g
Q8
T/c Postpartum Infection
Waiting Final Action 
05/08/2024
CO-AMOXICLAV 625MG (TAB)
05/08/2024
05/15/2024
PO
625mg
Bid
T/c Postpartum Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: